Abstract Describing Use of Oregovomab in Pancreatic Cancer to be Published in JCO as Part of ASCO 2018 Meeting

Induction of CA-125 Specific Immune Response by Oregovomab Chemoimmunotherapy in Pancreatic Cancer Patients EDMONTON, June 1, 2018 /PRNewswire/ - OncoQuest Inc. ("OncoQuest"), a privately held, cancer immunotherapy company, today announced the publication of an abstract, titled "A...